At the same time, protein acetylation has emerged as a prevalent posttranslational modification (PTM) in mitochondria to modulate enzymatic activity, and whether mitochondrial GLS acetylation is modulated to support hepatic tumour cell growth remains unknown. The gene discussed is GLS; the disease is neoplasm.